ENPICOM Announces Expansion of IGX Platform

ENPICOM, an innovative bioinformatics software engineering company, announced the upcoming expansion of the IGX Platform’s capabilities towards advanced liability prediction. At the Antibody Engineering and Therapeutics virtual conference, the company revealed its plans to integrate the Structural Antibody Prediction Platform (SAbPred) developed by researchers at the University of Oxford.

SAbPred is a widely recognized and validated tool developed by experts in molecular biology. While our team harbors a lot of knowledge in bioinformatics and software engineering, we believe this powerful combination brings the best of the two worlds. We are elevating our current platform capabilities and deliver an exceptional experience to antibody and vaccine developers looking for a more rapid, efficient, and reliable antibody discovery solution.” said Jos Lunenberg, co-founder and Chief Executive Officer at ENPICOM.

“We’re very excited to see Oxford Protein Informatics Group’s SabPred tools incorporated into ENPICOM’s IGX Platform. This collaboration will open the door for new users to apply our software to the structural analysis of antibodies.” said Fergus Boyles, Research Software Engineer at University of Oxford.

Enabling structural liability analysis at scale
Oxford researchers have developed SAbPred to perform various predictions of antibody properties that can support the discovery process and antibody design. The software helps study antibody properties and generate valuable information for developability potential of antibody candidates. SAbPred is currently used by leading biopharmaceutical companies to improve the design of antibody-based therapeutics.

By integrating SAbPred tools into the IGX Platform, ENPICOM allows scientists to apply the sophisticated algorithms to analyze high-throughput sequencing data inside the scalable and intuitive environment. This integration unlocks new antibody discovery workflows like performing structural analysis of proteins of interest and annotating important liability characteristics to select antibody candidates with good developability properties.

“The integration of SAbBox technology with ENPICOM’s IGX platform is great case study for impact from research at the Oxford University. We look forward to this launch as it will provide new ways of accessing the SabPred tools on a cloud-based platform.” said Sandeep Singh, Senior Licensing and Ventures Manager at Oxford University Innovation.

To learn more about the announcement at the Antibody Engineering and Therapeutics virtual conference, view the on-demand recording of the speaking session here.

SourceENPICOM

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."